Podcast
MSL Talk: Tom Caravela, Alec McCarthy
How to Start a Diversity Equity & Inclusion Program in Pharma
Summary
In this episode, Tara Gonzalez joins to discuss the intricacies of establishing Diversity, Equity, and Inclusion (DEI) programs within organizations. She shares insights from her background and outlines the challenges and strategies for initiating DEI initiatives. Tara emphasizes the importance of structuring DEI functions and engaging the entire company, while highlighting the role of external consultants in conducting needs assessments. The conversation covers best practices, the necessity of leadership buy-in, and the ongoing development of DEI efforts. Tara concludes with valuable advice for those looking to implement DEI programs, providing a comprehensive overview of this crucial topic.
This episode features Tara Gonzales, Vice President Medical Affairs discusses how to start a DEI program in Pharma
Tara shares….
👉 How she stood up a DEI program from scratch
👉 Why there is such a need for DEI programs
👉 What companies can expect as far as impact of a well run DEI program
👉 What it takes to build a positive culture in a company
Provide 5 keywords for SEO search separated by commas
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Alec McCarthy
Article
Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
Article
Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
Article
Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
Article
iNIZIO
Transforming oncology: Five frontiers driving progress in cancer care
Article
iNIZIO